Section snippets

Conflict of interest statement:

VTK and FEM have no conflicts to disclose. SZS received a one-time consultant for Siemens and a one-time talk supported by AbbVie. AK has served as speaker for Novo Nordisk, Norgine and Siemens and participated in advisory boards for Siemens, Boehringer Ingelheim and Novo Nordisk, all outside the submitted work. Research support; Astra, Siemens, Nordic Bioscience, Echosense. Board member and co-founder Evido. DLS has undertaken consultancy for Norgine Pharmaceuticals Ltd, EnteroBiotix, MRM

Specific author contributions:

VTK wrote the first draft of this manuscript. FEM, SZS, AK and DLS reviewed and revised the manuscript. All authors approved the final submitted manuscript.Protecting children against alcohol consumption is failing. The World Health Organization (WHO) report (2024) on adolescent substance use in Europe, Central Asia and Canada¹ serves as a compelling call to action to strengthen alcohol harm prevention strategies targeting the young.Substance use in adolescents is a major public health concern,

Funding:

No funding was received for the preparation of this manuscript.

中文翻译：

---

青少年的清醒受到围攻 – 紧急呼吁保护儿童免受酒精危害

 部分片段

利益冲突声明：

VTK 和 FEM 没有需要披露的冲突。SZS 获得了 Siemens 的一次性顾问和 AbbVie 支持的一次性讲座。AK 曾担任诺和诺德、诺吉恩和西门子的演讲者，并参与了西门子、勃林格殷格翰和诺和诺德的顾问委员会，所有这些都在提交的工作之外。研究支持;Astra、Siemens、Nordic Bioscience、Echosense。董事会成员兼联合创始人 Evido。DLS 曾为 Norgine Pharmaceuticals Ltd、EnteroBiotix、MRM 提供咨询

具体作者贡献：

VTK 撰写了这份手稿的初稿。FEM、SZS、AK 和 DLS 审查和修订了手稿。所有作者都批准了最终提交的手稿。保护儿童免受酒精消费是失败的。世界卫生组织 （WHO） 关于欧洲、中亚^{和加拿大青少年}物质使用的报告 （2024） 1 是一个令人信服的行动呼吁，以加强针对年轻人的酒精危害预防策略。青少年物质使用是一个主要的公共卫生问题，

 资金：

没有收到用于准备这份手稿的资金。